Parexel International Corp
Article Abstract:
Parexel International Corp.'s share net would have been higher without the restructuring charge started in 2001. Revenues are expected to increase out to 2006-2008 with timely shares and wide 3-5 years appreciation potential.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Pharmacopeia, Inc
Article Abstract:
Pharmacopeia, Inc. saw software revenue rise modestly, while drug discovery revenues rose by 23% in 2003. A comparative analysis of the company sales and financial details of from 1995 to 2003 are illustrated.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Pharmacopeia, Inc
Article Abstract:
Pharmacopeia, Inc. is expected to earn a small profit in 2003 and in 2004 and shares will have capital gains potential out to 2006-2008.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
User Contributions:
Comment about this article or add new information about this topic: